CircFoxo3 inhibited prostate cancer cell survival, migration, invasion and chemoresistance to docetaxel, which was related to circFoxo3s repression of Foxo3 and EMT.
Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.